Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1812 1
1813 1
1814 1
1911 1
1928 2
1930 1
1932 1
1933 1
1934 1
1945 2
1946 5
1947 5
1948 4
1949 3
1950 6
1951 5
1952 6
1953 5
1954 10
1955 10
1956 9
1957 13
1958 16
1959 16
1960 20
1961 25
1962 24
1963 22
1964 26
1965 20
1966 25
1967 38
1968 20
1969 35
1970 37
1971 29
1972 41
1973 40
1974 38
1975 66
1976 58
1977 72
1978 55
1979 47
1980 63
1981 67
1982 57
1983 73
1984 74
1985 107
1986 111
1987 94
1988 122
1989 102
1990 118
1991 110
1992 120
1993 131
1994 141
1995 154
1996 163
1997 140
1998 157
1999 155
2000 165
2001 137
2002 137
2003 128
2004 151
2005 178
2006 158
2007 156
2008 181
2009 186
2010 214
2011 236
2012 213
2013 258
2014 246
2015 222
2016 234
2017 214
2018 248
2019 197
2020 164
Text availability
Article attribute
Article type
Publication date

Search Results

6,747 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Younes A, Sehn LH, Johnson P, Zinzani PL, Hong X, Zhu J, Patti C, Belada D, Samoilova O, Suh C, Leppä S, Rai S, Turgut M, Jurczak W, Cheung MC, Gurion R, Yeh SP, Lopez-Hernandez A, Dührsen U, Thieblemont C, Chiattone CS, Balasubramanian S, Carey J, Liu G, Shreeve SM, Sun S, Zhuang SH, Vermeulen J, Staudt LM, Wilson W; PHOENIX investigators. Younes A, et al. Among authors: johnson p. J Clin Oncol. 2019 May 20;37(15):1285-1295. doi: 10.1200/JCO.18.02403. Epub 2019 Mar 22. J Clin Oncol. 2019. PMID: 30901302 Free PMC article. Clinical Trial.
Trichomonas vaginalis: Pathogenesis, Symbiont Interactions, and Host Cell Immune Responses.
Mercer F, Johnson PJ. Mercer F, et al. Among authors: johnson pj. Trends Parasitol. 2018 Aug;34(8):683-693. doi: 10.1016/j.pt.2018.05.006. Epub 2018 Jun 29. Trends Parasitol. 2018. PMID: 30056833 Review.
Targeting GLP-1 receptor trafficking to improve agonist efficacy.
Jones B, Buenaventura T, Kanda N, Chabosseau P, Owen BM, Scott R, Goldin R, Angkathunyakul N, Corrêa IR Jr, Bosco D, Johnson PR, Piemonti L, Marchetti P, Shapiro AMJ, Cochran BJ, Hanyaloglu AC, Inoue A, Tan T, Rutter GA, Tomas A, Bloom SR. Jones B, et al. Among authors: johnson pr. Nat Commun. 2018 Apr 23;9(1):1602. doi: 10.1038/s41467-018-03941-2. Nat Commun. 2018. PMID: 29686402 Free PMC article.
Increasing tolerance of hospital Enterococcus faecium to handwash alcohols.
Pidot SJ, Gao W, Buultjens AH, Monk IR, Guerillot R, Carter GP, Lee JYH, Lam MMC, Grayson ML, Ballard SA, Mahony AA, Grabsch EA, Kotsanas D, Korman TM, Coombs GW, Robinson JO, Gonçalves da Silva A, Seemann T, Howden BP, Johnson PDR, Stinear TP. Pidot SJ, et al. Among authors: johnson pdr. Sci Transl Med. 2018 Aug 1;10(452):eaar6115. doi: 10.1126/scitranslmed.aar6115. Sci Transl Med. 2018. PMID: 30068573
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N, Aikata H, Nagano H, Hatano E, Sasaki Y, Hino K, Kumada T, Yamamoto K, Imai Y, Iwadou S, Ogawa C, Okusaka T, Kanai F, Akazawa K, Yoshimura KI, Johnson P, Arai Y; SILIUS study group. Kudo M, et al. Among authors: johnson p. Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432. doi: 10.1016/S2468-1253(18)30078-5. Epub 2018 Apr 7. Lancet Gastroenterol Hepatol. 2018. PMID: 29631810 Clinical Trial.
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study.
Ueshima K, Nishida N, Hagiwara S, Aoki T, Minami T, Chishina H, Takita M, Minami Y, Ida H, Takenaka M, Sakurai T, Watanabe T, Morita M, Ogawa C, Hiraoka A, Johnson P, Kudo M. Ueshima K, et al. Among authors: johnson p. Cancers (Basel). 2019 Jul 7;11(7):952. doi: 10.3390/cancers11070952. Cancers (Basel). 2019. PMID: 31284682 Free PMC article.
Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation.
Wooderchak-Donahue WL, Johnson P, McDonald J, Blei F, Berenstein A, Sorscher M, Mayer J, Scheuerle AE, Lewis T, Grimmer JF, Richter GT, Steeves MA, Lin AE, Stevenson DA, Bayrak-Toydemir P. Wooderchak-Donahue WL, et al. Among authors: johnson p. Eur J Hum Genet. 2018 Oct;26(10):1521-1536. doi: 10.1038/s41431-018-0196-1. Epub 2018 Jun 11. Eur J Hum Genet. 2018. PMID: 29891884 Free PMC article.
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.
Sha C, Barrans S, Cucco F, Bentley MA, Care MA, Cummin T, Kennedy H, Thompson JS, Uddin R, Worrillow L, Chalkley R, van Hoppe M, Ahmed S, Maishman T, Caddy J, Schuh A, Mamot C, Burton C, Tooze R, Davies A, Du MQ, Johnson PWM, Westhead DR. Sha C, et al. Among authors: johnson pwm. J Clin Oncol. 2019 Jan 20;37(3):202-212. doi: 10.1200/JCO.18.01314. Epub 2018 Dec 3. J Clin Oncol. 2019. PMID: 30523719 Free PMC article.
Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide- and lenalidomide-containing regimens.
Storrar NPF, Mathur A, Johnson PRE, Roddie PH. Storrar NPF, et al. Among authors: johnson pre. Br J Haematol. 2019 Apr;185(1):142-144. doi: 10.1111/bjh.15392. Epub 2018 May 22. Br J Haematol. 2019. PMID: 29785771 No abstract available.
Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement.
Freeman SA, Vega A, Riedl M, Collins RF, Ostrowski PP, Woods EC, Bertozzi CR, Tammi MI, Lidke DS, Johnson P, Mayor S, Jaqaman K, Grinstein S. Freeman SA, et al. Among authors: johnson p. Cell. 2018 Jan 11;172(1-2):305-317.e10. doi: 10.1016/j.cell.2017.12.023. Cell. 2018. PMID: 29328918 Free PMC article.
6,747 results
Jump to page
Feedback